Pieter Smits
Latest contributions
The role of DCB in non-left main true bifurcations
22 May 2025 – From EuroPCR 2025
This session offers a detailed exploration of drug-coated balloon (DCB) use in non-left main true bifurcation lesions. Learn to define suitable lesion characteristics for provisional stenting, understand stepwise procedural strategies minimizing implanted material, and appreciate the role of intravascular imaging in assessing bifurcation complexity and optimizing...
Unraveling the full potential of computed tomography
22 May 2025 – From EuroPCR 2025
Delve into the expanding potential of computed tomography in cardiology. This session highlights high-risk plaque morphology, associations with invasive physiology, AI-powered plaque quantification, and advanced CT analyses predicting cardiac events.
The Landmark RCT - One-year results
21 May 2025 – From EuroPCR 2025
This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Multivessel disease in ACS - which lesions to treat and when
21 May 2024
Watch the replay of this webinar with S. Biscaglia, V. Paradies and P. Smits on how to learn about new evidence for complete revascularisation in ACS and much more!
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
New frontiers in coronary physiology and imaging
15 May 2024 – From EuroPCR 2024
Supraflex Cruz - Improving patient outcomes: from simple to complex patients
14 May 2024 – From EuroPCR 2024
Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...
5 year results from the COMPARE-ABSORB trial
27 Aug 2023
Mirvat Alasnag and Pieter C Smits discuss the design of the randomised controlled trial COMPARE-ABSORB and the 5-year results which he presented during the ESC Congress 2023 in Amsterdam.
Author
Author
EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on wire and image-based physiology
18 May 2023 – From EuroPCR 2023
Find out more about a series of studies focusing on wire and image based physiology: Coronary microvascular function and CT coronary angiography trial aiming to assess whether endotype diagnosis informed by coronay function testing vs angiography improved angina; a 5-year follow up of the DEFINE FLAIR;...
Coronary CT reading
18 May 2023 – From EuroPCR 2023
Watch this session to master reading and interpreting standard coronary CT angiography images, to learn how to determine lesion location, quantify stenosis, and to characterize plaques from CT imaging, while gaining the skills to differentiate between image artifacts and true coronary stenosis or plaques.
How should I treat a patient at high bleeding risk requiring complex PCI?
05 Nov 2020
Discover the replay of this webinar on high bleeding risk and complex PCI, with T. Cuisset, P. Smits and M. Valgimigli.
When coronary stents failed
20 May 2022 – From EuroPCR 2022
Watch this session consisting of five clinical cases in order to discover strategies for success, solutions and advice when faced with complications when coronary stents fail.
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
Embrace the innovation in PCI and TAVR: Robocath R-One vascular robot for PCI in China, MicroPort Firehawk TES stent, and VitaFlow valve
18 May 2022 – From EuroPCR 2022
The objective of this EuroPCR 2022 session is to highlight MicroPort's innovation portfolio in 3 different fields: learn more about the clinical performance of Firehawk Family stent in STEMI patients evaluated by imaging tools, the features and benefits of PCI robot R-ONE and first clinical trial updates in China,...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
EuroPCR 2021 Hotlines / Late-Breaking Trials in ACS: COOL AMI EU pivotal rial and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in ACS:
- COOL AMI EU pivotal trial
- Complete versus incomplete revascularization in NSTEMI patients
- Non-hyperaemic IMRangio and long-term clinical outcome in STEMI
Managing a patient with STEMI and bystander disease in the pandemic (Part 2) - Session with LIVE case
20 May 2021 – From EuroPCR 2021
Watch this session if you want to be updated on developments in treatment of ACS and STEMI, and to discuss diagnosis and treatment for bystander disease.
This session was originally presented during EuroPCR 2021.
Short DAPT in high bleeding risk: ready for prime time?
20 May 2021 – From EuroPCR 2021
Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...
What you need to know about DAPT in high-bleeding risk patients
12 Dec 2020 – From GulfPCR-GIM 2020
This educational session focuses on the high-bleeding risk situation in the Gulf Region, the latest evidence on HBR and how to integrate it into your practice, followed by challenging cases discussed by Mirvat Alasnag,Thomas Cuisset, Marco Valgimigli and Peter Smits.
